Lactosylated lipid calcium phosphate-based nanoparticles: A promising approach for efficient DNA delivery to hepatocytes

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 42

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-27-8_002

تاریخ نمایه سازی: 16 خرداد 1403

چکیده مقاله:

Objective(s): For safe and effective gene therapy, the ability to deliver the therapeutic nucleic acid to the target sites is crucial. In this study, lactosylated lipid phosphate calcium nanoparticles (lac-LCP) were developed for targeted delivery of pDNA to the hepatocyte cells. The lac-LCP formulation contained lactose-modified cholesterol (CHL), a ligand that binds to the asialoglycoprotein receptor (ASGR) expressed on hepatocytes, and polyethyleneimine (PEI) in the core.  Materials and Methods: Fourier transform infrared spectroscopy (FT-IR) and nuclear magnetic resonance (NMR) were used to monitor the chemical modification, and the physicochemical properties of NPs were studied using dynamic light scattering (DLS) and transmission electron microscopy (TEM). To evaluate transfection efficiency, cellular uptake and GFP expression were assessed using fluorescence microscopy and flow cytometry. Results: The results revealed that lactose-targeted particles (lac-LCP) had a significant increase in cellular uptake by hepatocytes. The inclusion of a low molecular weight PEI (۱.۸ KDa) with a low PEI/pDNA ratio of ۱ in the core of LCP, elicited high degrees of GFP protein expression (by ۵ and ۶-fold), which exhibited significantly higher efficiency than PEI ۱.۸ KDa and Lipofectamine. Conclusion: The successful functionalization and nuclear delivery of LCP NPs described here indicate its promise as an efficient delivery vector to hepatocyte nuclei.

نویسندگان

Masoomeh Khalifeh

Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Ali Badiee

Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Navid Ramezanian

Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran

Amirhossein Sahebkar

Applied Biomedical Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran

Atena Farahpour

Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran

Reza Kazemi Oskuee

Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Barros SA, Gollob JA. Safety profile of RNAi nanomedicines. Adv ...
  • Seth S, Johns R, Templin MV. Delivery and biodistribution of ...
  • Goswami R, Subramanian G, Silayeva L, Newkirk I, Doctor D, ...
  • Shahryari A, Saghaeian Jazi M, Mohammadi S, Razavi Nikoo H, ...
  • Zu H, Gao D. Non-viral vectors in gene therapy: Recent ...
  • Chung S, Lee CM, Zhang M. Advances in nanoparticle-based mRNA ...
  • Witzigmann D, Kulkarni JA, Leung J, Chen S, Cullis PR, ...
  • Ahmed M, Narain R. Carbohydrate-based materials for targeted delivery of ...
  • Snoeys J, Lievens J, Wisse E, Jacobs F, Duimel H, ...
  • Crispe IN. Hepatic T cells and liver tolerance. Nat Rev ...
  • Huang KW, Lai YT, Chern GJ, Huang SF, Tsai CL, ...
  • Zhou X, Zhang M, Yung B, Li H, Zhou C, ...
  • Zhang M, Zhou X, Wang B, Yung BC, Lee LJ, ...
  • Nasr M, Kira AY, Saber S, Essa EA, El-Gizawy SA. ...
  • Hu Y, Haynes MT, Wang Y, Liu F, Huang L. ...
  • Yao J, Fan Y, Li Y, Huang L. Strategies on ...
  • Malaekeh-Nikouei B, Gholami L, Asghari F, Askarian S, Barzegar S, ...
  • Sabin J, Alatorre-Meda M, Miñones J Jr, Domínguez-Arca V, Prieto ...
  • Sikor M, Sabin J, Keyvanloo A, Schneider MF, Thewalt JL, ...
  • Shi J, Chou B, Choi JL, Ta AL, Pun SH. ...
  • Casper J, Schenk SH, Parhizkar E, Detampel P, Dehshahri A, ...
  • Wu Y, Gu W, Xu ZP. Enhanced combination cancer therapy ...
  • Li J, Yang Y, Huang L. Calcium phosphate nanoparticles with ...
  • Tang J, Li L, Howard CB, Mahler SM, Huang L, ...
  • Schaffer DV, Fidelman NA, Dan N, Lauffenburger DA. Vector unpacking ...
  • Maestro S, Weber ND, Zabaleta N, Aldabe R, Gonzalez-Aseguinolaza G. ...
  • Kawakami S, Hashida M. Glycosylation-mediated targeting of carriers. J Control ...
  • D’Souza AA, Devarajan PV. Asialoglycoprotein receptor mediated hepatocyte targeting - ...
  • Li J, Chen YC, Tseng YC, Mozumdar S, Huang L. ...
  • Wilson G. Effect of reductive lactosamination on the hepatic uptake ...
  • Lundquist JJ, Toone EJ. The cluster glycoside effect. Chem Rev ...
  • Ma P, Liu S, Huang Y, Chen X, Zhang L, ...
  • Wang X, Qi Y, Liu L, Ganbold T, Baigude H, ...
  • Pathak PO, Nagarsenker MS, Barhate CR, Padhye SG, Dhawan VV, ...
  • Li H, Cui Y, Liu J, Bian S, Liang J, ...
  • Bodnar M, Hartmann JF, Borbely J. Preparation and characterization of ...
  • Jerzykiewicz J, Czogalla A. Polyethyleneimine-based lipopolyplexes as carriers in anticancer ...
  • Ewe A, Schaper A, Barnert S, Schubert R, Temme A, ...
  • Lampela P, Soininen P, Urtti A, Männistö PT, Raasmaja A. ...
  • Kunath K, von Harpe A, Fischer D, Petersen H, Bickel ...
  • Kazemi Oskuee R, Dabbaghi M, Gholami L, Taheri-Bojd S, Balali-Mood ...
  • نمایش کامل مراجع